Investigation of the therapeutic effects and mechanisms of Houpo Mahuang Decoction on a mouse model of chronic obstructive pulmonary disease
HPMHD was shown to alleviate COPD and reduce lung inflammation in mice, potentially through the activation of the IL-17 signaling pathway. This study provides a novel direction for the development of COPD drugs.
Authors
- Shanlan Li
- Ziqi Dai
- Haimin Lei
- Xiaomin Xiong
- Feng Gao
- Guanghui Jiang (ORCID: https://orcid.org/0000-0003-1236-180X)
- Yixuan Lin
- Nan Wang (ORCID: https://orcid.org/0009-0006-1132-8054)
- Tong Zhang (ORCID: https://orcid.org/0000-0002-2046-4502)
- Bing Xu (ORCID: https://orcid.org/0000-0003-1323-938X)
- Jin An
- Xuehao Cheng (ORCID: https://orcid.org/0009-0005-0099-8733)
- Zhuoqian Guo
Institutions
- Beijing University of Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-11-07
- DOI
- https://doi.org/10.3389/fphar.2024.1448069
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Hebei Province
- Beijing University of Chinese Medicine
- National Key Research and Development Program of China